These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8129214

  • 21. Bioequivalence of a generic slow-release theophylline tablet in children.
    Kanthawatana S, Ahrens RC, McCubbin M, Bronsky E, Blake K, Hendeles L.
    J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
    Stein GE, Haughey DB, Ross RJ, Vakoutis J.
    Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
    Rivera-Calimlim L, Calimlim JF, Liang R, Lasagna L, Diamond GL.
    J Asthma; 1986 Oct; 23(3):113-22. PubMed ID: 3528119
    [Abstract] [Full Text] [Related]

  • 27. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD, McKiernan BC, Neff-Davis CA, Munsiff IJ.
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of whole and half Theo-Dur tablets.
    Fagerström PO.
    Eur J Respir Dis Suppl; 1980 Sep; 109():62-6. PubMed ID: 6934089
    [Abstract] [Full Text] [Related]

  • 29. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M, Olivieri M, Lampronti G, Bonazza L, Biasin C, Nacci P, Talamini G, Lo Cascio V.
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
    Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I.
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
    [Abstract] [Full Text] [Related]

  • 32. Effects of time of dose in relation to food on the bioavailability of Theo-Dur Sprinkle at steady state in asthmatic children.
    Birkett DJ, Lines DR, Kneebone GM, Green B, Hughes HM.
    Clin Pharmacol Ther; 1989 Mar; 45(3):305-11. PubMed ID: 2920505
    [Abstract] [Full Text] [Related]

  • 33. Food effects on the nighttime pharmacokinetics of Theo-Dur tablets.
    Kann J, Levitt MJ, Horodniak JW, Pav JW.
    Ann Allergy; 1989 Oct; 63(4):282-6. PubMed ID: 2679244
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A pharmacokinetic study of the recommended dosing schedules of Theo-Dur and Uniphylline.
    Purkiss R, Cope A, Edwards C.
    Allergy; 1984 Nov; 39(8):634-8. PubMed ID: 6528959
    [Abstract] [Full Text] [Related]

  • 36. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K, Backman A, Björkstén F, Finnilä MJ.
    Allergol Immunopathol (Madr); 1988 Nov; 16(1):5-9. PubMed ID: 3381714
    [Abstract] [Full Text] [Related]

  • 37. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M, Okuma M, Uekusa T, Akimoto K, Obata T, Akazawa A, Odajima Y, Nagakura T, Iikura Y, Hukushima K.
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract] [Full Text] [Related]

  • 38. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL, Maddux MS, Organek HW, Bauman JL.
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.